Status:
WITHDRAWN
Acceptance and Commitment Therapy for Chemsex
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Chemsex
Eligibility:
MALE
18-65 years
Phase:
NA
Brief Summary
Quasi-randomized control trial of acceptance and commitment therapy (ACT) for chemsex.
Detailed Description
Intervention will entail a prescreening, intake session, 16 therapy sessions, and a six-month follow-up. Each session will be 45-55 minutes long. Participants in ACT-for-chemsex will be compared to pa...
Eligibility Criteria
Inclusion
- Male
- age 18-65
- access to internet capable smart device
- documentation of Alabama residence
- access to a private area to attend tele ACT-for-chemsex sessions
- self-reported chemsex within six-months of intake
- English fluency.
Exclusion
- Psychotic disorder
- bipolar disorder
- eating disorder
- major neurocognitive disorder diagnosis
- self-harm or suicide attempt within 12 months of screener
- suicide plan/intention at time of screening
- ongoing treatment for a complex medical comorbidity (e.g., in patient cancer treatment)
- current enrollment in an individual ACT-based psychotherapy intervention.
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2030
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06980974
Start Date
December 1 2025
End Date
December 31 2030
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233